Vitamin D(3) enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk

BACKGROUND: Vitamin D(3) (VitD) deficiency is linked to increased incidence and worse survival in bladder cancer (BCa). In addition to cystectomy, patients are treated with cisplatin‐based chemotherapy, however 30%‐50% of patients do not benefit from this treatment. The effects of VitD deficiency on...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Med
Prif Awduron: Bunch, Brittany L., Ma, Yingyu, Attwood, Kristopher, Amable, Lauren, Luo, Wei, Morrison, Carl, Guru, Khurshid A., Woloszynska‐Read, Anna, Hershberger, Pamela A., Trump, Donald L., Johnson, Candace S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2019
Pynciau:
Cancer Biology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537042/
https://ncbi.nlm.nih.gov/pubmed/30972950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2119
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg